Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending September 18, 2016
HCV Cirrhosis Patients: No Increased Diabetes Risk, Am J Gastroenterol; ePub 2016 Aug 16; Yang, et al
Higher Colorectal Adenomas Rate in HCV+ Patients , J Gastrointest Oncol; 2016 Aug; Hurtado-Cordovi, et al
Liver Disease Risk for Co-Infected Patients , Clin Infect Dis; ePub 2016 Aug 9; Klein, et al
Must reads for theWeek ending September 11, 2016
1 in 4 HCV Patients Have Critical Liver Disease, Clin Infect Dis; ePub 2016 Aug 9, Klevens, et al
Disparities Found In HCV Screening, Care Access, PLoS One; ePub 2016 Aug 15; Bourgi, Brar, et al
Must reads for theWeek ending September 4, 2016
Immune Activation Can Regress to Normal Levels, J Infect Dis; ePub 2016 Aug 11; Markowitz, et al
Specialty Care Received Varied Among HCV Patients, Dig Dis Sci; ePub 2016 Aug 10; Foster, Xing, et al
HCV Infection High Among Prison Entrants, Public Health Rep; 2016 Jul-Aug; Stockman, et al
Must reads for theWeek ending August 28, 2016
HIV/Hepatitis Coinfection, Low Muscle Mass Linked , AIDS; ePub 2016 Aug 3; Gowda, Brown, et al
Fibrous Progression in HCV Varies by Stage, J Infect Dis; ePub 2016 Aug 2; Zeremski, et al
Must reads for theWeek ending August 21, 2016
Statin Drug Use Mitigates Liver Disease in HCV, AIDS; ePub 2016 Aug 3; Oliver, Hartman, et al
Treatment Uptake Can Reduce HCV Burden by 2030, Epidemiol Infect; ePub 2016 Aug 5; Soipe, Razavi, et al
Spillover Effects of HIV Testing Observed, BMC Public Health; ePub 2016 Jul 29; Frimpong, et al